Navigation Links
NeurogesX to Present at Two November Conferences
Date:10/29/2009

SAN MATEO, Calif., Oct. 29 /PRNewswire-FirstCall/ -- NeurogesX, Inc. (Nasdaq: NGSX), a biopharmaceutical company focused on developing and commercializing novel pain management therapies, announced today that Anthony DiTonno, President and Chief Executive Officer, is scheduled to present at two upcoming conferences in New York City: the Oppenheimer & Co. 20th Annual Healthcare Conference, to be held November 3-4, 2009 and the Lazard Capital Markets 6th Annual Healthcare Conference, taking place November 17-18, 2009.

Mr. DiTonno and Stephen Ghiglieri, Chief Financial Officer, will also be available to respond to questions following the presentations and to participate in one-on-one meetings with investors attending the conferences.

    Event:   Oppenheimer & Co. Healthcare Conference
    Date:    Tuesday, November 3, 2009
    Time:    3:55 p.m. ET
    Place:   The Waldorf Astoria Hotel, NYC (East Foyer - Third Floor)

    Event:   Lazard Capital Markets Healthcare Conference
    Date:    Tuesday, November 17, 2009
    Time:    11:25 p.m. ET
    Place:   The St. Regis Hotel, NYC (Louis XVI A, Second Floor)

Both presentations will be webcast live and can be accessed by visiting the investor relations section of NeurogesX' website at www.neurogesx.com. The webcasts will be archived for 90 days.

About NeurogesX, Inc.

NeurogesX (Nasdaq: NGSX) is a biopharmaceutical company focused on developing and commercializing novel pain management therapies. Its initial focus is on chronic peripheral neuropathic pain, including postherpetic neuralgia (PHN), painful HIV-distal sensory polyneuropathy (HIV-DSP) and painful diabetic neuropathy (
'/>"/>

SOURCE NeurogesX, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. NeurogesX to Present at UBS Global Life Sciences Conference
2. NeurogesX to Present at Upcoming Fall Conferences
3. NeurogesX Appoints New Board Director and Audit Committee Chairman
4. NeurogesX Reports Second Quarter 2009 Results
5. NeurogesX Announces New PDUFA Date for Qutenza(TM) New Drug Application
6. NeurogesX to Hold Conference Call to Discuss Second Quarter 2009 Financial Results
7. NeurogesX Added to Russell 3000 Index
8. NeurogesX Provides U.S. Regulatory Update for Qutenza(TM)
9. NeurogesX to Present at Needham Life Sciences Conference
10. NeurogesX Receives European Commission Approval for Qutenza(TM)
11. NeurogesX Reports First Quarter 2009 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/22/2014)... have developed a unique nanoscale device that for ... The discovery could have major implications for creating ... and communication. , The research paper by University ... Mo Li and his graduate student Huan Li ... the October issue of Nature Nanotechnology . ...
(Date:9/22/2014)... 2014 US demand to rise 3.9% annually ... is forecast to rise 3.9 percent per year to ... projected to increase 1.3 percent per year to 1.5 ... in construction expenditures will support demand for biocides in ... growth in consumer spending and manufacturing output will support ...
(Date:9/22/2014)... -- Research and Markets has announced the ... Industry Report 2014" report to their offering. ... Report 2014 is a professional and in-depth study on ... with a focus on the Chinese situation. ... including definitions, classifications, applications and industry chain structure. The ...
(Date:9/22/2014)... D.C (PRWEB) September 22, 2014 FierceBiotech ... top privately held biotechnology companies of 2014. FierceBiotech ... companies before selecting this year’s winners. Those selected ... biotechnology companies in the industry. , "It's ... new group of Fierce 15 companies," said Carroll. "This ...
Breaking Biology Technology:Engineers show light can play seesaw at the nanoscale 2US Biocides Market 2US Biocides Market 3Global and Chinese Microcrystalline Cellulose Industry Report 2014 2FierceBiotech Announces Annual “Fierce 15” Winners of 2014 2
... industry will face many serious issues over the next ... rigors of engineering better biofuels and bioproducts. But few ... the 20,000 convention visitors at BIO '06. , ... ,A walk-through in Chicago's massive McCormick Place demonstrates just ...
... and discovery. From medicine to manufacturing, some of the ... our state. Today, amid a revolution in biotechnology and ... ,From developing innovative new sources of renewable energy that ... oil to working to find cures to Parkinson's, Alzheimer's ...
... Chicago The biotechnology industry has a job to ... luncheon attended by thousands at the BIO Chicago conference. , ... infectious diseases, guard against pandemics, create crops that can feed ... such as ethanol, and confront global warming head on. , ...
Cached Biology Technology:My-oh, it's BIO! Where sales hype and science collide 2Making Wisconsin the biotechnology leader 2Making Wisconsin the biotechnology leader 3Clinton says world needs biofuels, GM crops, and more answers 2Clinton says world needs biofuels, GM crops, and more answers 3
(Date:9/21/2014)... University of California, San Diego, have developed a program ... the activity of genes based on sequences of DNA. ... application to human embryonic cells in a paper published ... "All of our cells have the same blueprint, the ... Whitaker, lead author of the report. "Skin cells protect, ...
(Date:9/21/2014)... researchers has developed a protein therapy that disrupts the ... original tumor sites, travel through the blood stream and ... This process, known as metastasis, can cause cancer to ... patients who succumb to cancer fall prey to metastatic ... professor of bioengineering who describes a new therapeutic approach ...
(Date:9/19/2014)... of Oklahoma biology professor will study multifunctional and ... movements with a National Science Foundation grant in ... , Ari Berkowitz, professor in the Department of ... focus on the differences between the multifunctional and ... neurotransmitters they use and what connections they make. ...
Breaking Biology News(10 mins):Program predicts placement of chemical tags that control gene activity 2Stanford researchers create 'evolved' protein that may stop cancer from spreading 2Stanford researchers create 'evolved' protein that may stop cancer from spreading 3Stanford researchers create 'evolved' protein that may stop cancer from spreading 4
... to save a species in the 21st century? The specter ... as 35 percent, has some scientists and managers considering taking ... relocation (MR) is literally the physical relocation of endangered or ... and foreign geographical climes. It addresses the concern that climate ...
... at the National Institutes of Health have found that ... cell energy metabolism appear to increase the risk for ... the enzyme phosphodiesterase 11A (PDE11A), which helps regulate a ... studies by NIH researchers have linked genetic variations that ...
... greatly from our real-life partner, according to new research from ... France. The research found that our actual partners are of ... we would ideally choose. The study, which was ... PLoS ONE , found that most men and women express ...
Cached Biology News:Climate change forcing a 'move it or lose it' approach to species conservation? 2Climate change forcing a 'move it or lose it' approach to species conservation? 3Gene variations that alter key enzyme linked to prostate cancer 2Study shows real partners are no match for ideal mate 2
Rabbit polyclonal to STUB1 ( Abpromise for all tested applications). entrezGeneID: 10273 SwissProtID: Q9UNE7...
... which pioneered the blending of thermostable DNA ... Expand Long Template PCR Systems, now introduces ... the first product of a family of ... combines Taq DNA Polymerase with a novel ...
... polymers) are prepared by ... the enzyme, polynucleotide phosphorylase, ... the appropriate, ribonucleoside diphosphate ... exception of catalog number ...
... stainless-steel shaker flask clips, purpose-designed to firmly ... All clips are equipped with a top ... include a bottom retainer spring, and silicon ... expensive glassware. Clips include the required ...
Biology Products: